{"schema_version":"secwatch.filing_event.v1","accession":"0001555280-22-000266","form_type":"8-K","ticker":"ZTS","cik":"0001555280","company_name":"Zoetis Inc.","filed_at":"2022-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.129053+00:00","generated_at":"2026-06-23T01:17:56.205821+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Zoetis appoints Glenn David as EVP of U.S. Ops, Diagnostics, BioDevices; Jamie Brannan to International Ops","bullets":["Glenn David becomes EVP and Group President, U.S. Operations, Global Diagnostics and BioDevices effective Nov 1, 2022.","Jamie Brannan appointed EVP and Group President, International Operations and Aquaculture (PHARMAQ) effective same date.","Wafaa Mamilli, Chief Digital and Technology Officer, adds oversight of China, Brazil and Precision Animal Health."],"urls":{"canonical":"https://secwatch.observer/filing/0001555280-22-000266","json":"https://secwatch.observer/filing/0001555280-22-000266.json","markdown":"https://secwatch.observer/filing/0001555280-22-000266.md","text":"https://secwatch.observer/filing/0001555280-22-000266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/zts-20221024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T01:17:56.205821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04c09a5029","claim":"Wafaa Mamilli changed role as Chief Digital and Technology Officer at Zoetis Inc..","evidence_excerpt":"Wafaa Mamilli, the Company’s Chief Digital and Technology Officer, will also assume oversight of China, Brazil and Precision Animal Health, effective November 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"assume oversight"},{"label":"Role","value":"Chief Digital and Technology Officer"}],"fact_type":"executive_change"},{"claim_id":"3e5478fdc1","claim":"Jamie Brannan was appointed as Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ) at Zoetis Inc..","evidence_excerpt":"the Company has appointed Jamie Brannan, who currently serves as the Company’s President, International Operations, as the Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ), effective November 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Group President, International Operations and Aquaculture (PHARMAQ)"}],"fact_type":"executive_change"},{"claim_id":"d10d09b9a5","claim":"Glenn David was appointed as Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc..","evidence_excerpt":"Zoetis Inc. (the “Company”) appointed Glenn David as the Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective November 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1555280/000155528022000266/0001555280-22-000266-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}